ERBB2 and gastric cancer: Inspired by the above finding that two Hh inhibitors Cyc and Vis exerted anti-proliferation effects in HER2-positive GC cells, we further investigated the synergistic effects of Hh inhibitors and trastuzumab in HGC-27 cell line.